Atrial Fibrillation Early Recurrence After Cardioversion - Medscape
Atrial fibrillation recurrence is common, especially during the first 2 weeks, even when the patients are on antiarrhythmic therapy . . .
Coffee Drops Risk for Atrial Fibrillation, Flutter - Medscape
The DECAF trial shows that drinking one cup of caffeinated coffee a day may actually reduce atrial fibrillation or flutter.
A Coffee a Day to Keep the AFib Away? - Medscape
Michelle O’Donoghue and Gregory Marcus review the clinical implications of the DECAF randomized trial of caffeinated coffee or avoiding caffeine after successful cardioversion for …
ED Cardioversion Safe in Patients With Severe Obesity - Medscape
Sep 15, 2025 · ED cardioversion restores rhythm in patients with class III-IV obesity and atrial fibrillation or flutter, achieving a 92.3% success rate without any airway events, a study finds.
Electrical Cardioversion for AF -- The State of the Art
Aside from patient factors, a number of factors may influence the immediate success of cardioversion, that is, a complete failure to cardiovert. These include electrode placement, …
Better Late Than Never: SHAM-PVI Shows AF Ablation Works
Oct 10, 2024 · Electrophysiologist John Mandrola interviews Rick Veasey and Rajdip Dulai about the strengths and limits of the SHAM-PVI study, the first sham-controlled trial of atrial …
Optimal Pad Position in Transcutaneous Pacing - Medscape
Jan 11, 2023 · After successful cardioversion to sinus rhythm, the cardioversion pads were removed, and two new sets of pacer pads were placed on the patients' chests.
Adenosine Safe for Pediatric Tachyarrhythmia - Medscape
Sep 17, 2024 · A study found adenosine to be safe as a first-line treatment for pediatric supraventricular tachycardia, with no serious side effects observed during a decade of use.
FDA Approves First Pulsed Field Ablation System for AF - Medscape
Medtronic's PulseSelect Pulsed Field Ablation System was approved for the treatment of paroxysmal and persistent atrial fibrillation.
AF Ablation Works…But: SHAM PVI - Medscape
Sep 18, 2024 · The first sham-controlled trial of atrial fibrillation ablation with pulmonary vein isolation shows a placebo-resistant benefit, but questions remain about how it works, writes …